Cita APA

Kalra, N., Zhang, J., Yu, Y., Ho, M., Merino, M., Cao, L., & Hassan, R. (2012). Efficacy of anti-insulin like growth factor I receptor (IGF-IR) monoclonal antibody cixutumumab in mesothelioma is highly correlated with IGF-IR sites/cell.

Chicago Style Citation

Kalra, Neetu, Jingli Zhang, Yunkai Yu, Mitchell Ho, Maria Merino, Liang Cao, i Raffit Hassan. Efficacy of Anti-insulin Like Growth Factor I Receptor (IGF-IR) Monoclonal Antibody Cixutumumab in Mesothelioma Is Highly Correlated With IGF-IR Sites/cell. 2012.

Cita MLA

Kalra, Neetu, et al. Efficacy of Anti-insulin Like Growth Factor I Receptor (IGF-IR) Monoclonal Antibody Cixutumumab in Mesothelioma Is Highly Correlated With IGF-IR Sites/cell. 2012.